Table 1.
Characteristics of participants in the study
| Parameters | Women with type 1 diabetes (N = 36) | Controls (N = 64) | P |
|---|---|---|---|
| Age, y | 25.0 ± 5.6 | 24.8 ± 2.3 | .805 |
| Duration of diabetes, y | 14.1 ± 4.8 | – | – |
| MDI/CSII, n | 12/24 | – | |
| Weight, kg | 62.9 ± 15.2 | 60.7 ± 7.3 | .336 |
| BMI | 25.8 ± 5.0 | 23.7 ± 2.6 | .120 |
| Fasting glucose, mg/dL | 133.6 ± 42.9 | 76.0 ± 5.6 | < .001 |
| HbA1c, % | 7.7 ± 1.1 | 5.0 ± 0.6 | < .001 |
| SBP, mm Hg | 110.0 (110.0-112.5) | 110.0 (105.0-115.0) | .790 |
| DBP, mm Hg | 70.0 (65.0-70.0) | 67.5 (62.5-70) | .331 |
| Total cholesterol, mg/dL | 168.5 ± 20.8 | 163.0 ± 20.4 | .193 |
| HDL cholesterol, mg/dL | 60.7 ± 13.3 | 58.1 ± 8.4 | .233 |
| LDL cholesterol, mg/dL | 96.3 ± 15.7 | 101.2 ± 26.0 | .288 |
| Triglycerides, mg/dL | 57 (46, 65) | 61 (51, 66) | .098 |
| Creatinine, mg/dL | 0.80 ± 0.1 | 0.81 ± 0.01 | .443 |
Data are expressed as mean ± SD and as median (interquartile range).
Abbreviations: BMI, body mass index; CSII, continuous insulin infusion; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MDI, multiple daily injections; SBP, systolic blood pressure.